Hossam Abdulkhalek Presents Work on FOLFIRINOX Outcomes and NSCLC at ASCO 2026
Hossam Abdulkhalek/LinkedIn

Hossam Abdulkhalek Presents Work on FOLFIRINOX Outcomes and NSCLC at ASCO 2026

Hossam Abdulkhalek, Divisional Clinical Director of Cancer and Clinical Services at Western Health and Social Care Trust, shared a post on LinkedIn:

“Delighted to share that two of our team’s abstracts have been accepted for publication at the ASCO Annual Meeting 2026.

Our work highlights two areas of real-world impact for patients in Northern Ireland:

  • Delivering complex pancreatic cancer care locally with five-year FOLFIRINOX outcomes.
  • Improving guideline adherence in NSCLC through robust baseline neuroimaging practices.

Proud of the multidisciplinary effort behind these projects and the continued commitment to advancing high-quality cancer care for our region.”

Hossam Abdulkhalek

Other articles about ASCO on OncoDaily.